Quick Heal Technologies Limited (Quick Heal), India’s leading provider of IT Security Software Products and Solutions to individuals, businesses and Government, reported its reviewed and un-audited results for the quarter…Read More
Sun Pharma, India’s largest drug maker that has invested around USD 1 billion in the specialty business in the US, has so far found it to be a mixed bag due to…Read More
At the recently concluded MEDLAB expo, the ERBA Group, a leading global In-vitro Diagnostic Company, launched their latest hematology analyzers, H 360 and H 560. Designed for improving lab efficiency,…Read More
Alembic Pharmaceuticals announced after trading hours yesterday, 12 February 2019 that its wholly-owned step-down subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for…Read More
Piramal Foundation signed 4 Memorandums of Understanding (MoUs) with the Government of Maharashtra, to improve healthcare and access to safe drinking water, as part of the ‘Maha Parivartan’ initiative that…Read More
Pharma major Lupin announced the launch of Tadalafil Tablets USP 20mg, having received an approval from the United States Food and Drug Administration (FDA) earlier. Lupin’s Tadalafil Tablets USP 20mg…Read More
Strides Pharma Science Wednesday said its step-down wholly-owned subsidiary has received approval from the US health regulator for Triamcinolone Acetonide cream, used to treat a variety of skin conditions. The approved…Read More
Sun Pharma, India’s largest drug maker on February 12 said it it had responded to the two queries raised by stock market regulator the Securities and Exchange Board of India…Read More
Zydus Cadila has received the final approval from the USFDA to market Triamterene and Hydrochlorothiazide Capsules USP (US RLD – DYAZIDE), 37.5 mg/25 mg. It will be manufactured at the…Read More
Net Sales at Rs 573.49 crore in December 2018 up 6.61 percent from Rs. 537.93 crore in December 2017. Quarterly Net Profit at Rs. 1.46 crore in December 2018 up…Read More
Sun Pharmaceutical Industries Ltd. reported financials for the third quarter & nine month ending December 31st, 2018. Highlights of Q3FY19 consolidated financials: Sales/Income from operations at Rs. 7657 crores, growth…Read More
Dr. Reddy’s Laboratories Ltd. announced the launch of Tadalafil Tablets USP, a therapeutic equivalent generic version of Adcirca (tadalafil) Tablets in the United States market, approved by the U.S. Food…Read More
Alembic Pharmaceuticals Limited announced that its wholly owned step-down subsidiary Orit Laboratories LLC has received approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application…Read More
Pharma major Lupin announced that it has received approval for its Fluoxetine Tablets USP, 60mg, from the United States Food and Drug Administration (FDA) to market a generic version of…Read More
Glenmark Pharmaceuticals Inc., USA (Glenmark) has been granted final approval by the United States Food & Drug Administration (U.S. FDA) for Sevelamer Hydrochloride Tablets, 400 mg and 800 mg, a…Read More